ALK-2403

N/A

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameALK-2403
Drug Alias NameALK2403ALK-2403
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsChronic PainAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAilikang (Hefei) Medical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAilikang (Hefei) Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsChronic PainAcute Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A